About Caplin Steriles Limited
Data last updated: 17 December 2025
Caplin Steriles Limited is a public limited company based in Chennai, Tamil Nadu, India, a subsidiary of Caplin Point Laboratories Limited. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 12 December 2018, the company has been in operation for over 8 years.
Registered with ROC Chennai under CIN U24304TN2018PLC126270.
Capital: an authorised share capital of ₹190 Cr and a paid-up capital of ₹179.96 Cr. It is led by directors including Komattu Chacko John and Prem Venkatachalam Pavoor.
Last AGM: 08 September 2025. Financial statements filed for year ended 31 March 2025. Office: Chennai, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹377.24 Cr, a growth of 18% compared to the previous year.
The company has a workforce of approximately 1,003 employees as per the latest available data. It operates as a subsidiary of Caplin Point Laboratories Limited.
The company is associated with 1 brand - Caplin Steriles. As per MCA filings, the company has open charges of ₹4.94 Cr on record.
For more details, the company can be reached via its website caplinsteriles.net.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered Address3Rd Floor Ashvich Towers No.3 Developed Plots Industrial Estates Per, Ungudi, Chennai, Tamil Nadu, India – 600096
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Caplin Steriles Limited
Caplin Steriles Limited operates one associated brand: Caplin Steriles. These brands represent Caplin Steriles Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Developer and manufacturer of injectable products in vials, vyophilized vials and ophthalmic drops | caplinsteriles.net |
Business Activity of Caplin Steriles Limited
Caplin Steriles Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Caplin Steriles Limited
Caplin Steriles Limited is audited by MSKA & Associates for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MSKA & Associates | blur-value | blur-value | blur-value |
Board of Directors of Caplin Steriles Limited
Caplin Steriles Limited is currently managed by 9 directors, with 11 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Komattu Chacko John
Also directs:
Caplin Point Laboratories Limited
|
Director | 08 Aug 2019 | 6 Years 11 Months | Current |
|
Prem Venkatachalam Pavoor
Also directs:
Laurus Bio Private Limited, Immuneel Therapeutics Private Limited, Enzene Biosciences Limited and 3 more
|
Nominee Director | 07 Mar 2019 | 7 Years 4 Months | Current |
| Rengaraj Viswanathan | Director | 04 Jul 2023 | 3 Years 0 Months | Current |
| Ketan Mahendra Patel | Nominee Director | 02 Nov 2023 | 2 Years 8 Months | Current |
| Sridhar Ganesan | Whole-Time Director | 13 Jun 2022 | 4 Years 0 Months | Current |
|
Partheeban Vivek Siddarth
Also directs:
Caplin Point Laboratories Limited, Caplin One Labs Limited, Ashvich Properties Private Limited and 3 more
|
Director | 12 Dec 2018 | 7 Years 6 Months | Current |
Financials of Caplin Steriles Limited FY 2025 filings available
Caplin Steriles Limited reported revenue of ₹377.24 Cr (up 18% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Caplin Steriles Limited
As of FY 2022, Caplin Steriles Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Group Structure of Caplin Steriles Limited
Caplin Steriles Limited has 1 associated company. This group structure data is as of FY 2022. The corporate group structure reflects Caplin Steriles Limited's business expansion strategy and organizational complexity.
Charges & Borrowings of Caplin Steriles Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Mar 2025 | Others | ₹4.94 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Caplin Steriles Limited
Caplin Steriles Limited has a workforce of 1,003 employees as of Apr 05, 2024.
Employee Count & EPFO Data of Caplin Steriles Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Caplin Steriles Limited
GSTIN & GST Filing Data of Caplin Steriles Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Caplin Steriles Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Caplin Steriles Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Caplin Steriles Limited
MSME Payment Delays by Caplin Steriles Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Caplin Steriles Limited
Subsidiaries & Group Companies of Caplin Steriles Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Caplin Steriles Limited with ownership details.
MCA Filings & Documents of Caplin Steriles Limited
MCA Filings & Documents of Caplin Steriles Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Caplin Steriles Limited
Recent News on Caplin Steriles Limited
Frequently Asked Questions about Caplin Steriles Limited
Caplin Steriles Limited is an active public limited company in the pharma sector based in Chennai, Tamil Nadu, India. It was incorporated on 12 December 2018 (8+ years old) and is registered under CIN U24304TN2018PLC126270. The company has 1,003 employees.
Caplin Steriles Limited reported revenue of ₹377.24 Cr for FY 2025 (up 18.00% YoY).
The current directors of Caplin Steriles Limited are:
The primary industry of Caplin Steriles Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Caplin Steriles Limited can be reached at the registered office: 3Rd Floor Ashvich Towers No.3 Developed Plots Industrial Estates Per, Ungudi, Chennai, Tamil Nadu, India – 600096, or through the website caplinsteriles.net.
The authorised capital is ₹190 Cr, and the paid-up capital is ₹179.96 Cr.